Insomnia News and Research RSS Feed - Insomnia News and Research

Insomnia is too little or poor-quality sleep caused by one or more of the following:

Trouble falling asleep
Waking up a lot during the night with trouble returning to sleep
Waking up too early in the morning
Having un-refreshing sleep (not feeling well rested), even after sleeping 7 to 8 hours at night

Insomnia can cause problems during the day, such as excessive sleepiness, fatigue, trouble thinking clearly or staying focused, or feeling depressed or irritable. It is not defined by the number of hours you sleep every night. Although the amount of sleep a person needs varies, most people need between 7 and 8 hours of sleep a night.
Child adversities linked to high rates of adult insomnia

Child adversities linked to high rates of adult insomnia

According to a new study, child adversities, which are known to play an important role in mental and physical health, are also associated with poor sleep. [More]
Study characterizes benefits of over-the-counter sleep aid

Study characterizes benefits of over-the-counter sleep aid

New research shows that an over-the-counter sleep aid helps people suffering from occasional sleep difficulties fall asleep in less than 20 minutes, on average, and improves their reported quality of sleep. [More]
Natural tendency to self-restrict time in bed can protect against chronic insomnia

Natural tendency to self-restrict time in bed can protect against chronic insomnia

Twenty to 50 percent of Americans suffer from acute insomnia each year, defined as difficulty falling asleep or staying asleep, three or more nights per week, for between two weeks and three months. [More]
Almost half of female veterans have insomnia symptoms

Almost half of female veterans have insomnia symptoms

A new study sheds light on the prevalence of insomnia symptoms among female veterans. Results demonstrate that more than 47 percent of female veterans reported symptoms of insomnia that resulted in functional impairment. Of this sample group, less than one percent had a diagnosis of a sleep disorder based on medical records. [More]
PD surgery improves quality of life in patients with malignant pleural mesothelioma

PD surgery improves quality of life in patients with malignant pleural mesothelioma

Although surgery can prolong the lives of patients with an aggressive type of cancer called malignant pleural mesothelioma, many patients avoid the operation for fear it will degrade their quality of life. [More]
New research offers hope for patients struggling with major depression

New research offers hope for patients struggling with major depression

A new study reports that approximately two in five adults (39%) who have experienced major depression are able to achieve complete mental health. Researchers consider complete mental health as occurring when people achieve almost daily happiness or life satisfaction, positive social and psychological well-being, and are also free of depression, anxiety, suicidal thoughts and substance abuse for at least one full year. [More]
GFE3 protein may help researchers modify brain activity, memory in targeted ways

GFE3 protein may help researchers modify brain activity, memory in targeted ways

Scientists at USC have developed a new tool to modify brain activity and memory in targeted ways, without the help of any drugs or chemicals. [More]
Cobimetinib combined with vemurafenib shows added benefit for melanoma with BRAF V600 mutation

Cobimetinib combined with vemurafenib shows added benefit for melanoma with BRAF V600 mutation

Cobimetinib has been approved since November 2015 in combination with vemurafenib for the treatment of adults with advanced, i.e. metastatic or unresectable, melanoma with a BRAF V600 mutation. [More]
Military personnel with insomnia symptoms less resilient than members with healthy sleep hygiene

Military personnel with insomnia symptoms less resilient than members with healthy sleep hygiene

A new study found that military service members who reported insomnia symptoms or short sleep durations were less resilient than members who reported healthy sleep hygiene. [More]
Study assesses trends in antidepressant prescribing for depression

Study assesses trends in antidepressant prescribing for depression

In a study appearing in the May 24/31 issue of JAMA, Jenna Wong, M.Sc., of McGill University, Montreal, Canada, and colleagues analyzed treatment indications for antidepressants and assessed trends in antidepressant prescribing for depression. [More]
Telephone-based intervention helps reduce menopause-related insomnia, hot flashes

Telephone-based intervention helps reduce menopause-related insomnia, hot flashes

Chatting on the phone with a "sleep coach" and keeping a nightly sleep diary significantly improve sleep quality and reduce insomnia in women through all stages of menopause, according to a new study published today in JAMA Internal Medicine. [More]
New BMS survey highlights overlooked needs of women experiencing menopause

New BMS survey highlights overlooked needs of women experiencing menopause

A new survey conducted by Ipsos MORI on behalf of the British Menopause Society has revealed that one in two women in Great Britain go through the menopause without consulting a healthcare professional. [More]
Smartphones may have potential in treatment of insomnia

Smartphones may have potential in treatment of insomnia

An investigation published in the current issue of Psychotherapy and Psychosomatics indicates how the smartphone may have a potential in the treatment of insomnia. [More]
Short sleep duration along with frequent snoring may influence breast cancer survival

Short sleep duration along with frequent snoring may influence breast cancer survival

A new study reports that short sleep duration combined with frequent snoring reported prior to cancer diagnosis may influence subsequent breast cancer survival. [More]
Bupropion, varenicline drugs do not increase risk of serious neuropsychiatric adverse events

Bupropion, varenicline drugs do not increase risk of serious neuropsychiatric adverse events

Compared to the nicotine patch and a placebo, the smoking cessation aids varenicline (marketed as Chantix in the U.S.) and bupropion (Zyban) do not show a significant increase in neuropsychiatric adverse events, reports an international team of researchers in a study published online April 22 in the journal The Lancet. [More]
VIEKIRAX and EXVIERA achieve high SVR rates in GT1 and GT4 hepatitis C virus infected patients

VIEKIRAX and EXVIERA achieve high SVR rates in GT1 and GT4 hepatitis C virus infected patients

AbbVie, a global biopharmaceutical company, today announced new real-world data showing 96 percent of genotype 1 (GT1) patients (n=486/505 assessable for analysis) and 100 percent (n=53/53) of genotype 4 (GT4) patients achieved sustained virologic response at 12 weeks post-treatment (SVR12). [More]
Researchers analyze post-Ebola syndrome survivors to improve ongoing treatment

Researchers analyze post-Ebola syndrome survivors to improve ongoing treatment

Researchers from the University of Liverpool and the King's Sierra Leone Partnership are to present new findings into post-Ebola syndrome at a major European conference this week. [More]
New data from studies evaluating diagnostic tools, therapies for infectious diseases released at ECCMID 2016

New data from studies evaluating diagnostic tools, therapies for infectious diseases released at ECCMID 2016

New data from ten late-breaking abstracts is released at ECCMID 2016 – the annual meeting of the European Society of Clinical Microbiology and Infectious Disease. [More]
Janssen announces CHMP positive opinion for use of paliperidone palmitate 3-monthly injection for schizophrenia treatment

Janssen announces CHMP positive opinion for use of paliperidone palmitate 3-monthly injection for schizophrenia treatment

Janssen UK announced today that the Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the use of paliperidone palmitate 3-monthly injection for the maintenance treatment of schizophrenia in the European Union. [More]
Social microvolunteering app could support Alzheimer's caregivers

Social microvolunteering app could support Alzheimer's caregivers

Every day, more than 15 million unpaid caregivers provide care to people with Alzheimer's disease, with little outside support and often at the risk of their own health. [More]
Advertisement
Advertisement